# A Study in Germany to Learn About the Value of Fezolinetant in Treating Hot Flashes and Night Sweats in Women During Menopause

> **NCT07455812** · — · ACTIVE_NOT_RECRUITING · sponsor: **Astellas Pharma Europe Ltd.** · enrollment: 105 (actual)

## Conditions studied

- Hot Flashes

## Interventions

- **DRUG:** Fezolinetant

## Key facts

- **NCT ID:** NCT07455812
- **Lead sponsor:** Astellas Pharma Europe Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-10-29
- **Primary completion:** 2026-07-31
- **Final completion:** 2026-07-31
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2026-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07455812

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07455812, "A Study in Germany to Learn About the Value of Fezolinetant in Treating Hot Flashes and Night Sweats in Women During Menopause". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT07455812. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*